Form 4: Hologic Merger Completes, Insider Ownership Changes

Hologic, Inc. announces the completion of its merger, resulting in changes to insider beneficial ownership and the conversion of stock options and RSUs.

Summary

• Hologic, Inc. has completed its merger with Hopper Parent Inc. and Hopper Merger Sub Inc. as of April 7, 2026.
• Each share of Hologic common stock was converted into $76.00 in cash and one contingent value right (CVR) potentially worth up to $3.00.
• Insider Wendell Amy McBride's beneficial ownership of Hologic common stock has changed due to the merger.
• Outstanding stock options were cancelled and converted into cash payments or CVRs, depending on their exercise price relative to the merger consideration.
• Restricted stock unit awards were also converted into the right to receive the merger consideration.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While the merger provides a cash exit for shareholders, the contingent nature of a portion of the payout introduces uncertainty. The filing primarily details the mechanics of ownership change post-merger.

Positives

• The merger has been successfully completed, providing shareholders with cash consideration.
• Contingent value rights offer the potential for additional cash payments up to $3.00 per share.
• The transaction provides a clear exit for shareholders at a specified cash price.

Negatives

• Hologic, Inc. will cease to be a publicly traded entity, removing future public market participation for existing shareholders.
• The value of the CVR is contingent and not guaranteed, introducing uncertainty for a portion of the potential payout.

Risks

• The payment of the contingent value right (CVR) is subject to specific conditions and may not be fully realized or paid at all.
• The merger agreement outlines conditions under which options are cancelled for no consideration if their exercise price is too high.

Future Outlook

The future outlook for Hologic, Inc. as a standalone public entity is concluded due to the merger. The future value for former shareholders is tied to the payout of the contingent value rights (CVRs) which are dependent on specific future events and conditions.

Management Comments

• Wendell Amy McBride, a Director, no longer beneficially owns any shares of Company Common Stock directly or indirectly as a result of the Merger.

Industry Context

StockSavvy.ai notes that this Form 4 filing reflects a significant event in the life cycle of a public company, indicating a transition from public to private ownership. Such mergers are common in the healthcare technology sector, often driven by strategic consolidation or private equity interest seeking to restructure or unlock value away from public market scrutiny.

Stakeholder Impact

• Shareholders: Receive $76.00 per share in cash plus a contingent value right (CVR) potentially worth up to $3.00 per share.
• Option Holders: Outstanding options are cancelled and converted into cash payments or CVRs, with some options potentially cancelled for no consideration.
• RSU Holders: Restricted stock units are converted into the right to receive the merger consideration.
• Employees: May be impacted by changes in employment terms or roles under the new ownership structure, though not explicitly detailed in this filing.

Next Steps

• Shareholders will receive the cash consideration and contingent value rights.
• The contingent value rights will be subject to their specific terms and conditions for potential future payout.

Key Dates

Keywords

merger, Hologic, Hopper Parent Inc., Hopper Merger Sub Inc., insider ownership, stock options, restricted stock units, contingent value right, SEC Form 4, beneficial ownership